What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer

Dunlop, E. et al. (2022) What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer. Supportive Care in Cancer, 30(4), pp. 3141-3150. (doi: 10.1007/s00520-021-06724-6) (PMID:34878587) (PMCID:PMC8857102)

[img] Text
260299.pdf - Published Version
Available under License Creative Commons Attribution.

975kB

Abstract

Objective: To identify what matters to clinicians and patients when discussing cancer medicines’ impact on health-related quality of life (HRQoL). Methods: A framework of HRQoL domain/domain elements was developed, informed by analysis of published patient reported outcome measures (PROMs), applicable to prostate cancer. Using mixed methods (eDelphi, Nominal Group Technique and questionnaire), prostate cancer clinicians and patients attending prostate cancer clinics and support groups were asked which domains/domain elements would be important to them when discussing the impact prostate cancer medicines have on their HRQoL. Results: Twenty-one clinicians and 71 patients participated from the West of Scotland. Clinicians and patients identified 53/62 domain elements across seven domains as important, of which 32 (60%) were common to both groups. Clinicians placed more importance than patients on Mood & Emotion; in contrast, patients placed importance on a broader range of Symptoms & Side Effects, being informed about their care, and having effective healthcare professional collaboration. Conclusion: This study provides insight into the similarities and differences between what clinicians and patients think is important when discussing the impact of cancer medicines on HRQoL. Future research should involve exploring the potential for consistency of medicines PROMs across different cancer types to support patient-clinician communication and drive improvements in care.

Item Type:Articles
Additional Information:The Cancer Medicines Outcomes Programme (CMOP) is funded by the Scottish Government.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Glen, Dr Hilary and Wu, Professor Olivia and Jones, Professor Robert
Authors: Dunlop, E., Ferguson, A., Mueller, T., Baillie, K., Clarke, J., Laskey, J., Kurdi, A., Wu, O., Jones, R., Glen, H., and Bennie, M.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
College of Medical Veterinary and Life Sciences > Institute of Health and Wellbeing > Health Economics and Health Technology Assessment
Journal Name:Supportive Care in Cancer
Publisher:Springer
ISSN:0941-4355
ISSN (Online):1433-7339
Published Online:08 December 2021
Copyright Holders:Copyright © 2021 The Authors
First Published:First published in Supportive Care in Cancer 30(4): 3141-3150
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record